These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 26086727)

  • 1. Biased and inadequate citation of prior research in reports of cardiovascular trials is a continuing source of waste in research.
    Sawin VI; Robinson KA
    J Clin Epidemiol; 2016 Jan; 69():174-8. PubMed ID: 26086727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic examination of the citation of prior research in reports of randomized, controlled trials.
    Robinson KA; Goodman SN
    Ann Intern Med; 2011 Jan; 154(1):50-5. PubMed ID: 21200038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
    Conen D; Torres J; Ridker PM
    Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute.
    Gordon D; Cooper-Arnold K; Lauer M
    J Am Heart Assoc; 2015 Jul; 4(8):e002292. PubMed ID: 26231845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citation bias favoring statistically significant studies was present in medical research.
    Jannot AS; Agoritsas T; Gayet-Ageron A; Perneger TV
    J Clin Epidemiol; 2013 Mar; 66(3):296-301. PubMed ID: 23347853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of contradicted claims in the literature.
    Tatsioni A; Bonitsis NG; Ioannidis JP
    JAMA; 2007 Dec; 298(21):2517-26. PubMed ID: 18056905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: Problems with Russian Publications.
    Verbitskaya EV
    Int J Risk Saf Med; 2015; 27 Suppl 1():S89-90. PubMed ID: 26639728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.
    Chan AW; Krleza-Jerić K; Schmid I; Altman DG
    CMAJ; 2004 Sep; 171(7):735-40. PubMed ID: 15451835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publication bias of randomized controlled trials in emergency medicine.
    Ospina MB; Kelly K; Klassen TP; Rowe BH
    Acad Emerg Med; 2006 Jan; 13(1):102-8. PubMed ID: 16365332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals.
    Etter JF; Stapleton J
    J Clin Epidemiol; 2009 Aug; 62(8):831-7. PubMed ID: 19128941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uncertainty principle and industry-sponsored research.
    Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
    Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The architecture of clinical research (From the "Biostatistics and Epidemiology Lecture Series, Part 1").
    Stoller JK
    Cleve Clin J Med; 2017 Sep; 84(9 Suppl 2):e2-e9. PubMed ID: 28937357
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.
    Yusuf S; Wittes J; Probstfield J; Tyroler HA
    JAMA; 1991 Jul; 266(1):93-8. PubMed ID: 2046134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals.
    Wayant C; Scott J; Vassar M
    JAMA; 2018 Nov; 320(17):1813-1815. PubMed ID: 30398593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citation analysis did not provide a reliable assessment of core outcome set uptake.
    Barnes KL; Kirkham JJ; Clarke M; Williamson PR
    J Clin Epidemiol; 2017 Jun; 86():153-159. PubMed ID: 28342906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated legacy effects from simulated post-trial data were less biased than from combined trial/post-trial data.
    Zhu L; Bell KJL; Hayen A
    J Clin Epidemiol; 2019 Oct; 114():30-37. PubMed ID: 31128221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Heart Protection Study and bias in the interpretation of RCTs.
    Conradi P; Taylor D
    J Eval Clin Pract; 2005 Aug; 11(4):405-7. PubMed ID: 16011653
    [No Abstract]   [Full Text] [Related]  

  • 20. Negative Control Outcomes: A Tool to Detect Bias in Randomized Trials.
    Arnold BF; Ercumen A
    JAMA; 2016 Dec; 316(24):2597-2598. PubMed ID: 28027378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.